Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Market Cap	10.69B
Revenue (ttm)	2.41B
Net Income (ttm)	417.95M
Shares Out	206.30M
EPS (ttm)	2.00
PE Ratio	25.91
Forward PE	21.56
Dividend	1.27 (2.45%)
Ex-Dividend Date	May 19, 2025

Volume	89,562
Average Volume	370,349
Open	52.10
Previous Close	51.80
Day's Range	51.55 - 52.20
52-Week Range	43.98 - 60.95
Beta	0.53
RSI	53.29
Earnings Date	May 8, 2025

About BIT:REC

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1926
• Employees: 4,583
• Stock Exchange: Borsa Italiana
• Ticker Symbol: REC

Financial Performance

In 2024, BIT:REC's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.